Melatonin treatment does not affect insulin resistance of night shift workers

Melatonin treatment does not affect the insulin resistance or the glucose tolerance of night shift workers, according to a new study from the University of Surrey and the University Medical Centre Hamburg.

24 Executive Healthcare AI Predictions & Trends to Watch in 2025

From AI-powered diagnostics to personalized medicine, we asked twenty four healthcare executives their insights on trends and technologies that will transform patient care in the

January 16, 2025

MHRA approves Pierre Fabre’s vibegron to treat OAB

The asset is indicated for the treatment of overactive bladder syndrome symptoms in adult patients. Credit: New Africa / Shutterstock. The UK Medicines and Healthcare

July 18, 2024

Setback for UK pharma as government sets unexpectedly high VPAG payback rate in 2025 – Pharmaceutical Technology

The UK Department of Health and Social Care (DHSC) has announced its anticipated 2025 headline payback rate for new medicines under the 2024–2028 Voluntary Scheme

December 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.